Ceredex Value Advisors’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,250
Closed -$118K 164
2023
Q3
$118K Hold
3,250
﹤0.01% 145
2023
Q2
$122K Sell
3,250
-238,989
-99% -$9.62M ﹤0.01% 151
2023
Q1
$11.2M Sell
242,239
-13,600
-5% -$635K 0.17% 136
2022
Q4
$11.9M Buy
+255,839
New +$11.6M 0.18% 127

Other funds holding G

Ceredex Value Advisors's G Position: Q4 2023 in Review

Ceredex Value Advisors sold out of Genpact (G) in Q4 2023, closing a stake of 3,250 shares — an estimated $118K sold.

Ceredex Value Advisors first reported a position in G in Q4 2022 and held it in 4 quarters. The position peaked at $11.9M in Q4 2022. 355 funds tracked by Wall St. Rank hold G as of Q4 2023.

  • Ceredex Value Advisors reported no remaining Genpact position as of Q4 2023 after selling out during the quarter.
  • Ceredex Value Advisors sold 3,250 Genpact shares in Q4 2023, an estimated $118K.
  • Ceredex Value Advisors first reported a position in Genpact in Q4 2022 and held it in 4 quarters.
  • Ceredex Value Advisors's Genpact position peaked at $11.9M in Q4 2022.
  • 355 funds tracked by Wall St. Rank held Genpact as of Q4 2023.

Based on Ceredex Value Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.